Latest Reports

Pharmaceutical Key Opinion Leader Management (PH183)

Examine thought leader management team structures, staffing and budgets.  Benchmark pharmaceutical key opinion leader segments for the top three pharma thought leader tiers, five company sizes and 26 therapeutic areas.

 
Post-Patent Generic and Biosimilar Defense Strategies (PH181)

Create robust counter-generics strategies to retain products’ market share and prevent revenue erosion after patent expiration.

 
Medical Affairs (PH184)

Explore the medical affairs organization’s structure and resources as teams take on more medical communication, health economics and thought leader development responsibilities.

 
Promotional Speaker Programs (PH182)

Prepare promotional speaker program teams for the Sunshine Act by refocusing events on medical messages, adapting speaker bureaus, fine-tuning event management and recruiting speakers.

 
Oncology Clinical Trials (PH180)

Benchmark oncology clinical trials’ key metrics, including cost-drivers, duration, staffing and budgets.

 
Educational Speaker Programs (PH179)

Prepare for the Sunshine Act by adapting educational speaker program teams, speaker recruitment tactics and event management.

 
Pharmaceutical New Product Planning (PH176)

Create a strong commercial voice to best position developing brands for future success.

 
Optimizing Clinical Pharmacology Programs (PH173)

Manage critical Phase I cost-drivers and prevent expensive delays to move projects through early-stage trials.

 
Pharmaceutical Mobile Health (PH174)

Explore in-depth mobile health (mHealth) data including mobile team structures, usage of mHealth initiatives, best practices and 10 mobile application case studies. 

 
Pharmaceutical Launch Sequencing (PH172)

Explore pharmaceutical launch sequencing factors, manage the impact of reference pricing and prepare for future growth in key emerging markets.